MN SF2444

School districts and charter schools must maintain a supply of opiate antagonists at each school site, with each building required to have at least two doses of nasal naloxone available on-site, effective July 1, 2023.

The Commissioner of Health must develop and disseminate a training video on naloxone administration to schools, and at least one trained staff member must be on-site whenever the school building is open to students, staff, or the public, including before/after school and weekend activities.

Expands authorization for opiate antagonist administration to include any school personnel employed by or under contract with a school board, charter school, or private school, in addition to existing categories like emergency medical responders and peace officers.

Requires standing orders or protocols from licensed physicians, advanced practice registered nurses, or physician assistants before individuals can administer opiate antagonists, along with mandatory training on overdose recognition and response.

Appropriates funds from the general fund to the Department of Education for fiscal years 2024 and 2025 to reimburse school districts and charter schools for purchasing required opiate antagonist supplies.